ACCESS-AD

access-ad.bsky.social

21 October 2026 12:49

EPND+ launches at #IHIForum2026, continuing the legacy of the EPND project. ACCESS-AD will build on EPND infrastructure to share clinical, imaging, biomarker & real-world data, advancing timely diagnosis, treatment & monitoring of Alzheimer’s disease www.eurekalert.org/news-release...

AD-RIDDLE

ad-riddle.bsky.social

21 October 2026 11:50

Today at #IHIForum2026, EPND announced the launch of EPND+, an independent non-profit organisation that will sustain and develop the EPND Hub. AD-RIDDLE is already building on this foundation to advance Alzheimer’s research. Read the press release here: www.eurekalert.org/news-release...

ACCESS-AD

access-ad.bsky.social

20 October 2026 09:55

We're looking forward to 2 inspiring days on translating research into long-term impact at @ihieurope.bsky.social #IHIForum26 🇧🇪 Some of our members will join discussions & Carolina Pamplona will present an ACCESS-AD poster. Stop by to learn more about our project www.ihi.europa.eu/news-events/...

ERA4TB

era4tb.bsky.social

19 October 2026 13:30

The final ERA4TB consortium meeting kicked off in Alcalá de Henares today. With the project drawing to a close, it's a valuable opportunity to reflect on progress, share updates and agree next steps. Looking forward to productive discussions as we work towards successful project completion.

RealiseD

realised-ihi.bsky.social

19 October 2026 13:30

🧠RealiseD at the European Colloquium on Epilepsy Clinical Trial! Organised by the ECET, #RealiseD coordinator Ralf-Dieter Hilgers participated with the presentation "Innovative Trial Design in Developmental and Epileptic Encelophaties - A RealiseD perspective." #IHI #Epilepsies